The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
about
Q24186229Creating an effective clinical registry for rare diseasesRisk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsRecent advances in the diagnosis and treatment of primary biliary cholangitis.Why Doesn't Primary Biliary Cholangitis Respond to Immunosuppressive Medications?Prognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidProposed therapies in primary biliary cholangitis.Early Molecular Stratification of High-risk Primary Biliary Cholangitis.It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology.Finding the cure for primary biliary cholangitis - Still waiting.Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.Geoepidemiology and changing mortality in primary biliary cholangitis.Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.Novel strategies and therapeutic options for the management of primary biliary cholangitis.Treatment of PBC-A step forward.A Randomized Trial of Obeticholic Acid Monotherapy in Patients with Primary Biliary Cholangitis.Editorial: scoring systems in primary biliary cholangitis - time to make a move. Authors' reply.The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.Editorial: scoring systems in primary biliary cholangitis - time to make a move.A brief review on prognostic models of primary biliary cholangitis.The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines.Investigational drugs in phase II clinical trials for primary biliary cholangitis.NELFCD and CTSZ loci are associated with jaundice-stage progression in primary biliary cholangitis in the Japanese population.External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.Clinical application of the GLOBE and United Kingdom-primary biliary cholangitis risk scores in a trial cohort of patients with primary biliary cholangitis.Increased expression and altered localization of cathepsin Z are associated with progression to jaundice stage in primary biliary cholangitis
P2860
Q24186229-52BB589D-C719-48A6-8E56-26058C7EC8F0Q26741126-D2351642-2764-4739-968B-2D901230D8B5Q26796355-84ACA4A2-80D3-4A7D-9799-1E8E15D4D6DAQ28076353-E1BCDB75-B64E-423E-BB42-3554AB027CA5Q33840969-5F05D4F0-D54D-4838-9539-8BD929D200EAQ33920325-8E943D68-2964-4BBB-AA43-CB4CDAA344A1Q37072380-9A46E352-954F-4518-ADA8-3ED77D2C9C07Q37510232-E1854DA3-6ED7-406F-BBDE-86852DDACD19Q38620686-0787DD38-FC75-47FC-B493-E90AC08E2FB7Q38858980-9371AA13-545F-46E8-A67A-2A590A0F94BCQ39176767-14E9A8D5-9BF5-4EF6-9C63-8A650A5AFBE0Q39213467-B2ED6EA2-C15B-44D6-8E57-91C7E859D71BQ39584105-D22E1BB9-47AE-4EE1-9AD8-3F7C6ABAEDA3Q42330772-6FBFAA00-B5AB-4087-9CB7-2BB898670699Q42375647-FADFCD97-B19B-4FD7-B2AF-5B2D6036FFF3Q44129027-71AE2CE8-BC9F-4E44-BA72-8625EBB2B5F8Q45069872-4E6A6F7C-7C11-477F-B232-46120BFDC9CBQ46156296-8A1510AB-E8DE-49C3-89EA-14E297D7988FQ46813053-AB05360F-1F3F-4B0F-87CF-4CCDD94EBFA6Q47114292-2E49889F-15F8-4EED-A85E-B5A5325C7913Q47205297-DB4EEA86-F9DD-4B4F-85FC-B32F7FF1F11AQ47615113-B4E16735-09C5-4DD2-9FB6-57E223F9B225Q47787189-43EA6902-5595-4560-BFDD-2FFF20AAD86BQ48094960-C32EF78E-2EFD-4243-9BA0-099D780940DBQ48342063-D7DB148A-EC52-41AA-8AD5-142FFBE6273BQ52624982-3D013F96-2D16-405E-A408-05B54B6866C0Q53098304-8C67B98D-83AC-4464-83B9-1781A30B7754Q55049196-289D4141-2B38-49F1-B2B4-6B961A6513A7Q55332862-55A87147-27F7-4E19-A29F-200E6A86C68EQ55394717-84150DAA-B8C8-47F4-BF0E-0AF22A427138Q57112362-3D7F3868-0346-4B5B-AC81-EF01DF227ACD
P2860
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The UK-PBC risk scores: Deriva ...... n primary biliary cholangitis.
@en
type
label
The UK-PBC risk scores: Deriva ...... n primary biliary cholangitis.
@en
prefLabel
The UK-PBC risk scores: Deriva ...... n primary biliary cholangitis.
@en
P2093
P2860
P356
P1433
P1476
The UK-PBC risk scores: Deriva ...... in primary biliary cholangitis
@en
P2093
Andrew Bathgate
Andrew K Burroughs
Carolyn Adgey
David E J Jones
Dimitrios Paximadas
Douglas Thorburn
George F Mells
Gideon M Hirschfield
Graeme J Alexander
James M Neuberger
P2860
P304
P356
10.1002/HEP.28017
P407
P577
2015-07-29T00:00:00Z